360 related articles for article (PubMed ID: 11454905)
1. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
J Pharmacol Exp Ther; 2001 Aug; 298(2):453-60. PubMed ID: 11454905
[TBL] [Abstract][Full Text] [Related]
2. Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes.
Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):546-54. PubMed ID: 11138847
[TBL] [Abstract][Full Text] [Related]
3. In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.
Schaffhauser H; Richards JG; Cartmell J; Chaboz S; Kemp JA; Klingelschmidt A; Messer J; Stadler H; Woltering T; Mutel V
Mol Pharmacol; 1998 Feb; 53(2):228-33. PubMed ID: 9463480
[TBL] [Abstract][Full Text] [Related]
4. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
Johnson BG; Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
Neuropharmacology; 1999 Oct; 38(10):1519-29. PubMed ID: 10530814
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
[TBL] [Abstract][Full Text] [Related]
6. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
Howson PA; Jane DE
Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
8. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
Mistry R; Golding N; Challiss RA
Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
[TBL] [Abstract][Full Text] [Related]
9. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.
Kingston AE; Ornstein PL; Wright RA; Johnson BG; Mayne NG; Burnett JP; Belagaje R; Wu S; Schoepp DD
Neuropharmacology; 1998; 37(1):1-12. PubMed ID: 9680254
[TBL] [Abstract][Full Text] [Related]
10. (2S,1'S,2'R,3'R)-2(2'-Carboxy-3'-hydroxymethylcyclopropyl)glycine-[3H], a potent and selective radioligand for labeling group 2 and 3 metabotropic glutamate receptors.
Wheeler WJ; Clodfelter DK; Collado I; Kulanthaivel P; Pedregal C; Stoddard EA; Wright RA; Schoepp DD
Bioorg Med Chem Lett; 2005 Jan; 15(2):349-51. PubMed ID: 15603952
[TBL] [Abstract][Full Text] [Related]
11. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
Cahusac PM; Wan H
Neuroscience; 2007 Apr; 146(1):202-12. PubMed ID: 17346894
[TBL] [Abstract][Full Text] [Related]
12. Characterization of (2S,2'R,3'R)-2-(2',3'-[3H]-dicarboxycyclopropyl)glycine binding in rat brain.
Mutel V; Adam G; Chaboz S; Kemp JA; Klingelschmidt A; Messer J; Wichmann J; Woltering T; Richards JG
J Neurochem; 1998 Dec; 71(6):2558-64. PubMed ID: 9832156
[TBL] [Abstract][Full Text] [Related]
13. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
[TBL] [Abstract][Full Text] [Related]
14. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
Odagaki Y; Kinoshita M; Toyoshima R
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
[TBL] [Abstract][Full Text] [Related]
15. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats.
Celuch SM; García Mdel C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):343-9. PubMed ID: 12237748
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes.
Nishi N; Odagaki Y; Koyama T
Br J Pharmacol; 2000 Aug; 130(7):1664-70. PubMed ID: 10928972
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
[TBL] [Abstract][Full Text] [Related]
18. Activation of group II mGlu receptors inhibits voltage-gated Ca2+ currents in myenteric neurons.
Chen WP; Kirchgessner AL
Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1282-9. PubMed ID: 12388194
[TBL] [Abstract][Full Text] [Related]
19. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic visualization of group III metabotropic glutamate receptors using [3H]-L-2-amino-4-phosphonobutyrate.
Hudtloff C; Thomsen C
Br J Pharmacol; 1998 Jul; 124(5):971-7. PubMed ID: 9692783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
